mercredi 9 mai 2012

Afusertib, inolisib, nesvacumab, nindetanib

Anticancer drug names under consideration by the United States Adopted Names (USAN) Program:
afusertib, inolisib, nesvacumab, nindetanib

A name published in the USP Dictionary of USAN and International Nonproprietary Names, and on the United States Adopted Names Web site, shall be the effective equivalent of an intellectual property right on the part of the relevant entities.

afursertib:  treatment of hematological cancers

inolisib:  treatment of cancer

nesvacumab:  treatment of cancer

nintedanib:  antineoplastic

Aucun commentaire:

Enregistrer un commentaire